Christof Koch's Ascent

Courtesy of Christof Koch Scaling what climbers call "big wall," Yosemite's Half Dome appears impossible at the start: A rock face nearly 500 times taller than a person offers only shard-like holds and fingernail-thin cracks for support. But with talent, experience, and enormous focus and discipline, the big wall becomes a series of small, concentrated moves. The climber keeps focused, while the gawkers below admire his courage and question his sanity. California Institute of Technology profes

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Scaling what climbers call "big wall," Yosemite's Half Dome appears impossible at the start: A rock face nearly 500 times taller than a person offers only shard-like holds and fingernail-thin cracks for support. But with talent, experience, and enormous focus and discipline, the big wall becomes a series of small, concentrated moves. The climber keeps focused, while the gawkers below admire his courage and question his sanity. California Institute of Technology professor Christof Koch, researcher into the neurobiology of consciousness is an accomplished rock climber.

Koch has ascended the wall of neurobiology for more than a decade. In 1990, he and Nobel laureate Francis Crick challenged biologists' skepticism about studying consciousness. In their 1990 Seminars in Neuroscience paper,1 Crick and Koch swept away centuries of philosophical speculation about the so-called mind/body problem in one stroke of scientific pragmatism: Forget trying to define consciousness, just go out and discover it. As ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Karen Heyman

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo